Organic and Acquisitive Growth in Sales and Results; Critical Mass Reached for Sales Success; High Upside Potential Present
SYGNIS AG, headquartered in Heidelberg, is a life sciences company listed on the Prime Standard of the
Deutsche Börse. The company focuses on the development and marketing of innovative molecular biology
technologies in the NGS (next-generation sequencing) sector. Its most important products currently on the
market are TruePrimeTM (DNA amplification), SunScriptTM (transcribing RNA into DNA), RunBlue (DNA and
protein separation and purification) and Lightning Link (DNA and protein labeling) which are sold both
through their own marketing and by non-exclusive sales partners. Other products (e.g., DNA amplification
under liquid biopsy) should also make entry possible into high-volume diagnostic markets (e.g. hospitals).
SYGNIS AG acquired Expedeon Holdings Ltd. and C.B.S. Scientific in 2016 as part of its acquisitive growth
strategy. This expanded its product spectrum in the proteomics area, the second most important market
segment for molecular biology. Innova Bioscience Ltd was acquired in 2017, resulting in further vertical
expansion of the product range.
Die GBC AG mit Sitz in Augsburg ist eines der führenden bankenunabhängigen Investmenthäuser in Deutschland und erfahrener Emissionsexperte für den deutschen Mittelstand.
Die GBC AG kennt als eigentümergeführtes Unternehmen die Bedürfnisse des deutschen Mittelstandes im Finanzierungsbereich und ist ein unabhängiger und verlässlicher Partner bei allen Fragestellungen rund um den Kapitalmarkt.
In der GBC Gruppe bietet die GBC AG Unternehmensanalysen & Research, Kapitalmarkt- & Finanzierungsberatungen sowie Kapitalmarktkonferenzen.
Die GBC Kapital GmbH ergänzt die Leistungen in der Gruppe um das Corporate Finance in den Bereichen Platzierung & Vermittlung von Anleihen und Aktien
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.